GTR Test Accession:
Help
GTR000613129.1
Registered in GTR:
2024-01-04
View version history
GTR000613129.1,
registered in GTR:
2024-01-04
At a Glance
Test purpose:
Help
Diagnosis
Conditions (8):
Help
Disorder of sex development of gynecological interest;
Down syndrome (Trisomy 21) Patau syndrome (Trisomy 13) Edwards syndrome (Trisomy 18) Klinefelter syndrome (47,XXY) Turner syndrome (45, XO), and aneuploidies corresponding to the 46 chromosome screening;
Klinefelter syndrome
more...
Methods (1):
Help
Cytogenetics - Karyotyping: G-banding
Target population: Help
کاریوتایپینگ به عنوان یک آزمایش برای شناسایی و تشخیص اختلالات …
Clinical validity:
Help
Not provided
Clinical utility:
Help
Establish or confirm diagnosis
Ordering Information
Offered by:
Help
Specimen Source:
Help
- Amniocytes
- Amniotic fluid
- Bone marrow
- Chorionic villi
- Fetal blood
- Fresh tissue
- Peripheral (whole) blood
- View specimen requirements
Who can order: Help
- Genetic Counselor
- Health Care Provider
- In-State Patients
- Licensed Physician
- Out-of-State Patients
- Public Health Mandate
Contact Policy:
Help
Post-test email/phone consultation regarding genetic test results and interpretation is provided to patients/families.
How to Order:
Help
Visit the online reception page
Order URL
Order URL
Informed consent required:
Help
Yes
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Recommended fields not provided:
Test Order Code,
Lab contact for this test,
Test strategy,
Test development
Conditions
Help
Total conditions: 8
Condition/Phenotype | Identifier |
---|
Test Targets
Chromosomal regions/Mitochondria
Help
Total chromosomal regions/mitochondria: 6
Chromosomal region/Mitochondrion | Associated condition |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Karyotyping
G-banding
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Diagnosis
Clinical utility:
Help
Target population:
Help
کاریوتایپینگ به عنوان یک آزمایش برای شناسایی و تشخیص اختلالات کروموزومی در اختلالات جنسی، هیپوسپادیاس پروگزیمال، سندرم ترنر، سندرم داون، سندرم کلاین فلتر، سقط های مکرر و الیگواسپرمی و آزواسپرمی استفاده می شود.
Variant Interpretation:
Are family members with defined clinical status recruited to assess significance of VUS without charge?
Help
No.
No.
Will the lab re-contact the ordering physician if variant interpretation changes?
Help
Yes.
Yes.
Recommended fields not provided:
Clinical validity,
What is the protocol for interpreting a variation as a VUS?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
Accuracy and reliability of the test is 99.9%.
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
No
CAP Testing Information Help
CAP/ACMG Cytogenetics, Booklet; Chromosomal abnormalities; CYBK
CAP/ACMG Cytogenetics, Booklet; Karyotype nomenclature; CYBK
No
CAP Testing Information Help
CAP/ACMG Cytogenetics, Booklet; Chromosomal abnormalities; CYBK
CAP/ACMG Cytogenetics, Booklet; Karyotype nomenclature; CYBK
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
PT Provider,
Description of PT method
Regulatory Approval
FDA Review:
Help
Not provided
Additional Information
Reviews:
Clinical resources:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.